Close Menu

Which Comes First?

Razib Khan at Discover's Gene Expression blog says there is "a chicken-and-egg problem with personal genomics." More specifically, until sequencing personal genomes becomes ubiquitous and the process transparent, he says they will be somewhat of a "letdown in terms of what it can, or can't, tell us." At the same time, he adds, "as long as there’s a letdown, it won’t become ubiquitous and transparent." So, which will come first? Time will tell, Khan says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.